Latest Taro Pharmaceutical Industries News & Updates

See the latest news and media coverage for Taro. We track all announcements, press releases, and industry mentions in real time, all in one place.

Taro Pharmaceutical Industries (Taro)

Generic pharmaceutical and consumer healthcare company

taro.com

Headquarters: United States
Company type: Public company
Number of employees: 1,200–5,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Taro Pharmaceutical Industries (Taro)

In short: Taro Pharmaceutical Industries Ltd. finalized a $348 million merger with Sun Pharma and reported its Q4 2024 financial results.

Company announcements

23 May 2024 Taro

Taro shareholders approved merger with Sun Pharma

The merger was approved at meetings on May 22, 2024, and is expected to close in about 35 days, pending conditions.

17 January 2024 Taro

Taro announces merger agreement with Sun Pharma

Sun Pharma will acquire all outstanding Taro shares for US$43.00 per share in cash.

14 September 2013 Taro

Taro Pharma announces USFDA approval for generic Prevacid

The generic lansoprazole delayed-release capsules are approved by the FDA.

4 June 2013 Taro

Taro announces USFDA approval for generic Depo-Testosterone Injection

This approval allows Taro to market a generic alternative to Depo-Testosterone Injection.

Media coverage

July 6 Stockhouse

FINAL TARO DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Taro Pharmaceutical Industries Ltd. Investors to Join the Class Action Lawsuit!

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased...

25 December 2025 Hindustan Times

Sun Pharma's Taro recalls over 17,000 units of antifungal shampoo in US amid safety concerns

Taro Pharmaceutical Industries, a unit of Sun Pharma, is recalling over 17,000 units of an antifungal medication in the US due to manufacturing issues, according...

29 October 2025 Law360

Taro Pharma Beats Investor Suit Over $43-Per-Share Buyout - Law360

A New York federal judge tossed a proposed class action brought by minority shareholders of Taro Pharmaceutical Industries Ltd. that alleged the company and its...

6 November 2024 Morningstar

TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class ...

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased...

Never miss news about Taro

Track Taro and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Taro competitors & trending companies

Browse news for competitors to Taro and other trending companies.